Abstract:
An infusion management system includes an infusion management server configured for providing an order to an infusion device to administer an infusion and the infusion device. The infusion device may be configured for receiving the order, associating the order with a patient, and adjusting at least one setting according to the order. A method for administering an infusion, an interface for an infusion device and a computer program product are also disclosed.
Abstract:
Laterally cyano-substituted terphenyls of formula (I), wherein R.sup.1 and R.sup.2 are independently selected from hydrogen or C.sub.1-15 alkyl, alkoxy, or alkyl or alkoxy in which one or more CH.sub.2 groups are replaced by O, COO, OOC, CHX, CX.sub.2, CH=CX, CX=CH, CX=CX, where X is fluorine or chlorine. CRCN where R is alkyl, or C.tbd.C or in which a terminal CH.sub.3 of the said alkyl or alkoxy chain is replaced by CF.sub.3, n is 0 or 1, and the CN and F (if present) substituent are independently located in any of the available substitution positions. Liquid crystal materials containing these terphenyls are also described.
Abstract:
Compounds which may be used as a dopant or host in a ferroelectric chiral smectic liquid crystal mixture. The compounds are characterized in that they are derivates of an X-hydroxy carboxylic acid and contain the chiral unit (I), in which Ro may be alkyl, alkoxy, halogen, formula (II), where b may be 0 to 3 and the phenyl ring may be substituted, and a is 0 or 1. The chiral unit is combined with a range of mesogenic combinations of groups. Lactic acid derivatives are described in detail (i.e. Ro.dbd.methyl) together with various preparative routes, for example the compound formula (III), which has dopant properties in a range of hosts.
Abstract:
A compound suitable for use in a ferroelectric smectic liquid crystal composition having a structure which contains two chiral centers derived from alpha hydroxy carboxylic acid groups and having the formula: ##STR1## wherein R.sub.1 is n-alkoxy containing 1-12 carbo atoms and R.sub.2 is n-alkyl containing 1-12 carbon atoms. Methods of preparation and details of liquid crystal mixtures containing these compounds are described.
Abstract:
Novel derivatives of cyclic and acyclic terpenoid alcohols, having general formula (I) X--(CO).sub.n --O--T.sub.1, where n=O or l, T.sub.1 is a terpenoid group and X is a combination of cyclic groups, e.g. phenyl, cyclohexyl and pyrimidyl, X preferably contains up to three cyclic groups. Preferred derivatives are esters of cyclic terpenoid alcohols, e.g. menthol, borneol and isopineocampheol, e.g. formula (II) (-)-menthol. Ferroelectric smectic liquid crystal mixtures and devices containing these derivatives as chiral dopants in a tilted smectic host are also described. The properties of various other derivatives of terpenoid alcohols of formula (I) are also described, e.g. those of neomenthol, isolongifolol, fenchol, carveol, myrthenol, nopol, citronellol, perilla alcohol and dihydrocitronellol.
Abstract:
A heterocyclically substituted ethane having a formula:R.sub.1 -Cy-CH.sub.2.CH.sub.2 -A-R.sub.2 Formula 1whereinA represents a heterocyclic ring selected from a trans 2,5 disubstituted 1,3 dioxan ring and a 2,5 disubstituted 1,3-pyrimidine ring;R.sub.1 represents an alkyl group having from 1 to 15 carbon atoms and R.sub.2 represents a group selected from hydrogen, alkyl having from 1 to 15 carbon atoms and alkoxy having from 1 to 15 carbon atoms provided that where A is a trans 2,5 disubstituted 1,3 dioxan ring R.sub.2 is alkyl; andCy represents a trans-1,4 disubstituted cyclohexane ring.
Abstract:
A novel liquid crystal compound has a formula: ##STR1## where: ##STR2## is a trans-2,5-disubstituted-1,3-dioxan ring or a 2,5-disubstituted-1,3-imidine ring ##STR3## is a 1,4-disubstituted benzene ring optionally containing one or more F, Cl or CH.sub.3 groups as lateral substituents; R.sub.1 is an alkyl group; andX is a terminal group selected from H, CN, Cl, F and R.sub.2 where R.sub.2 is selected from alkyl R.sub.3, alkoxy OR.sub.3, alkylcarbonyloxy OCOR.sub.3 and alkoxycarbonyloxy OCOOR.sub.3.
Abstract:
A dye compound suitable for use in solution with a liquid crystal material is characterized by one of the following formulae: ##STR1## (III) a derivative of (I) or (II) containing one or more simple lateral substituents or bridging groups on the benzene rings: ##STR2## where n.sub.1, n.sub.2, n.sub.3 are integers in the range 0 to 4, A is azo or azoxy, X is cyano, or nitro and Y.sub.1 and Y.sub.2 are one of the following: hydrogen, alkoxy, arylalkoxy or N.sub.R.sbsb.2.sup.R.sbsp.1 where R.sub.1 and R.sub.2 are alkyl, substituted alkyl or alkylene groups.
Abstract:
Optically active compounds of formula (I), where X has a structure (II) and B is C.sub.1-12 alkyl, a chiral group or a group having a general structure (III), where R and R' are H, C.sub.1-12 alkyl, alkoxy, alkylcarbonyloxy, or alkoxycarbonyl, each ring (IV) and (V) is the same or different, A and D are single bonds or bridging groups, each a and d is 0 or 1; Z, Z' are CN, Cl, F, Br or CF.sub.3 ; provided when Z is CN or Cl, then when B is alkyl X-Y is not (VI) or (VII). Ferroelectric smectic liquid crystal mixtures containing these compounds are also described. ##STR1##